Repurposing erectile dysfunction drugs tadalafil and vardenafil to increase bone mass
Author(s) -
SeMin Kim,
Charit Taneja,
Helena PérezPeña,
Vitaly Ryu,
Anisa Gumerova,
Wenliang Li,
Naseer Ahmad,
Ling-Ling Zhu,
Peng Liu,
Mehr Mathew,
Funda Korkmaz,
Sakshi Gera,
Damini Sant,
Elina Hadelia,
Kseniia Ievleva,
TanChun Kuo,
Hirotaka Miyashita,
Li Liu,
Irina L. Tourkova,
Sarah A. Stanley,
Daria Lizneva,
Jameel Iqbal,
Li Sun,
Ronald Tamler,
Harry C. Blair,
Maria I. New,
Shozeb Haider,
Tony Yuen,
Mone Zaidi
Publication year - 2020
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2000950117
Subject(s) - tadalafil , vardenafil , erectile dysfunction , medicine , osteoporosis , repurposing , urology , pharmacology , bone remodeling , endocrinology , biology , ecology
Significance Tadalafil and vardenafil are among the most widely used drugs for erectile dysfunction, which affects nearly 19% of men over 20 y of age. Older men also suffer from age-related bone loss resulting in crippling fractures. We show that in mice, both agents act on bone cells, resulting in the formation of new bone and reduced removal of old bone. Because of this net gain in bone mass, we posit that tadalafil and vardenafil could be used for cotreating erectile dysfunction and osteoporosis in men of advancing age, as well as for treating osteoporosis in postmenopausal women. We recommend future clinical studies to establish the capability of these drugs to increase bone density and reduce fracture risk in humans.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom